117 related articles for article (PubMed ID: 22543856)
21. 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM).
Hoffrogge R; Mikkat S; Scharf C; Beyer S; Christoph H; Pahnke J; Mix E; Berth M; Uhrmacher A; Zubrzycki IZ; Miljan E; Völker U; Rolfs A
Proteomics; 2006 Mar; 6(6):1833-47. PubMed ID: 16475233
[TBL] [Abstract][Full Text] [Related]
22. Quantitative proteome and phosphoproteome analysis of human pluripotent stem cells.
Muñoz J; Heck AJ
Methods Mol Biol; 2011; 767():297-312. PubMed ID: 21822884
[TBL] [Abstract][Full Text] [Related]
23. Improved membrane proteomics coverage of human embryonic stem cells by peptide IPG-IEF.
McQuade LR; Schmidt U; Pascovici D; Stojanov T; Baker MS
J Proteome Res; 2009 Dec; 8(12):5642-9. PubMed ID: 19899800
[TBL] [Abstract][Full Text] [Related]
24. Identification of mouse embryonic stem cell-associated proteins.
Baharvand H; Fathi A; Gourabi H; Mollamohammadi S; Salekdeh GH
J Proteome Res; 2008 Jan; 7(1):412-23. PubMed ID: 18047272
[TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.
Vester D; Rapp E; Gade D; Genzel Y; Reichl U
Proteomics; 2009 Jun; 9(12):3316-27. PubMed ID: 19504497
[TBL] [Abstract][Full Text] [Related]
26. Human pluripotent stem cells for disease modelling and drug screening.
Maury Y; Gauthier M; Peschanski M; Martinat C
Bioessays; 2012 Jan; 34(1):61-71. PubMed ID: 22038777
[TBL] [Abstract][Full Text] [Related]
27. Concise review: Genomic stability of human induced pluripotent stem cells.
Martins-Taylor K; Xu RH
Stem Cells; 2012 Jan; 30(1):22-7. PubMed ID: 21823210
[TBL] [Abstract][Full Text] [Related]
28. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.
Aoki T; Ohnishi H; Oda Y; Tadokoro M; Sasao M; Kato H; Hattori K; Ohgushi H
Tissue Eng Part A; 2010 Jul; 16(7):2197-206. PubMed ID: 20146561
[TBL] [Abstract][Full Text] [Related]
29. Deciphering the complexities of human diseases and disorders by coupling induced-pluripotent stem cells and systems genetics.
Chang WY; Garcha K; Manias JL; Stanford WL
Wiley Interdiscip Rev Syst Biol Med; 2012; 4(4):339-50. PubMed ID: 22492636
[TBL] [Abstract][Full Text] [Related]
30. Identification of cytoplasmic and membrane-associated complexes in human embryonic stem cells using blue native PAGE.
Shekari F; Taei A; Pan TL; Wang PW; Baharvand H; Salekdeh GH
Mol Biosyst; 2011 Sep; 7(9):2688-701. PubMed ID: 21727978
[TBL] [Abstract][Full Text] [Related]
31. Proteomic analysis of membrane proteins expressed specifically in pluripotent murine embryonic stem cells.
Intoh A; Kurisaki A; Yamanaka Y; Hirano H; Fukuda H; Sugino H; Asashima M
Proteomics; 2009 Jan; 9(1):126-37. PubMed ID: 19053146
[TBL] [Abstract][Full Text] [Related]
32. Generation of human induced pluripotent stem cells from a Bombay individual: moving towards "universal-donor" red blood cells.
Seifinejad A; Taei A; Totonchi M; Vazirinasab H; Hassani SN; Aghdami N; Shahbazi E; Yazdi RS; Salekdeh GH; Baharvand H
Biochem Biophys Res Commun; 2010 Jan; 391(1):329-34. PubMed ID: 19912985
[TBL] [Abstract][Full Text] [Related]
33. Self-organizing map of gene regulatory networks for cell phenotypes during reprogramming.
Zhang L; Zheng Y; Li D; Zhong Y
Comput Biol Chem; 2011 Aug; 35(4):211-7. PubMed ID: 21864790
[TBL] [Abstract][Full Text] [Related]
34. Multipotent adult germline stem cells and embryonic stem cells functional proteomics revealed an important role of eukaryotic initiation factor 5A (Eif5a) in stem cell differentiation.
Dihazi H; Dihazi GH; Jahn O; Meyer S; Nolte J; Asif AR; Mueller GA; Engel W
J Proteome Res; 2011 Apr; 10(4):1962-73. PubMed ID: 21344951
[TBL] [Abstract][Full Text] [Related]
35. Lonely death dance of human pluripotent stem cells: ROCKing between metastable cell states.
Ohgushi M; Sasai Y
Trends Cell Biol; 2011 May; 21(5):274-82. PubMed ID: 21444207
[TBL] [Abstract][Full Text] [Related]
36. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells.
Pick M; Stelzer Y; Bar-Nur O; Mayshar Y; Eden A; Benvenisty N
Stem Cells; 2009 Nov; 27(11):2686-90. PubMed ID: 19711451
[TBL] [Abstract][Full Text] [Related]
37. A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs.
Choi J; Lee S; Mallard W; Clement K; Tagliazucchi GM; Lim H; Choi IY; Ferrari F; Tsankov AM; Pop R; Lee G; Rinn JL; Meissner A; Park PJ; Hochedlinger K
Nat Biotechnol; 2015 Nov; 33(11):1173-81. PubMed ID: 26501951
[TBL] [Abstract][Full Text] [Related]
38. Genetic manipulation of human induced pluripotent stem cells.
Wang A; Liew CG
Curr Protoc Stem Cell Biol; 2012 Nov; Chapter 5():Unit 5B.2. PubMed ID: 23154936
[TBL] [Abstract][Full Text] [Related]
39. The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells.
Munoz J; Low TY; Kok YJ; Chin A; Frese CK; Ding V; Choo A; Heck AJ
Mol Syst Biol; 2011 Nov; 7():550. PubMed ID: 22108792
[TBL] [Abstract][Full Text] [Related]
40. Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis.
Pripuzova NS; Getie-Kebtie M; Grunseich C; Sweeney C; Malech H; Alterman MA
Stem Cell Res; 2015 May; 14(3):323-38. PubMed ID: 25840413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
